Tanvex BioPharma, Inc. logo

Tanvex BioPharma, Inc.

TWSE:6541.TW

Overview | Financials
Company Name Tanvex BioPharma, Inc.
Symbol 6541.TW
Currency TWD
Price 70
Market Cap 11,484,970,000
Dividend Yield 0%
52-week-range 35.05 - 80
Industry Biotechnology
Sector Healthcare
CEO Dr. Yun Yen F.A.C.P., FACP, M.D., Ph.D.
Website https://www.tanvex.com

An error occurred while fetching data.

About Tanvex BioPharma, Inc.

Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III

Related Stocks

ScinoPharm Taiwan, Ltd. logo

ScinoPharm Taiwan, Ltd.

1789.TW

24.9 TWD

Grape King Bio Ltd logo

Grape King Bio Ltd

1707.TW

144 TWD

Adimmune Corporation logo

Adimmune Corporation

4142.TW

27.25 TWD

YungShin Global Holding Corporation logo

YungShin Global Holding Corporation

3705.TW

57 TWD

Pegavision Corporation logo

Pegavision Corporation

6491.TW

404 TWD

Excelsior Medical Co., Ltd. logo

Excelsior Medical Co., Ltd.

4104.TW

87.7 TWD

Panion & Bf Biotech Inc. logo

Panion & Bf Biotech Inc.

1760.TW

88.4 TWD

SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc.

4119.TW

88.3 TWD

Standard Chem & Pharm CO., LTD. logo

Standard Chem & Pharm CO., LTD.

1720.TW

64.8 TWD

China Chemical & Pharmaceutical Co., Ltd. logo

China Chemical & Pharmaceutical Co., Ltd.

1701.TW

21.15 TWD

Financials

Numbers are in millions USD

Numbers are in millions USD